Spire Healthcare Group plc (SPI.L) | Investment Case

1. Company Snapshot

1.a. Company Description

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics.It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.

In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health.Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans.It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland.

Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Show Full description

1.b. Last Insights on SPI

Spire Healthcare Group's recent performance is driven by its robust financial performance, as evidenced by the initiation of a share buyback program to enhance shareholder value. The company's strong fundamentals, including new contracts and technological investments, position it for growth despite challenges such as low return on equity and high net debt. Additionally, the company's fundamentals look strong, with a decent share price growth of 10% in the last month, according to recent market analysis.

1.c. Company Highlights

Last Price	176.2
Change Percentage	-2.76%
Open	181.2
Previous Close	181.2
Market Cap ( Millions)	709
Volume	4524365
Year High	256.5
Year Low	168.2
M A 50	230.41
M A 200	211.7

FCF Yield	18.75%
Dividend Yield	1.31%
ROE	2.50%
Debt / Equity	176.18%
Net Debt / EBIDTA	594.21%
Price To Book	0.98
Price Earnings Ratio	38.69
Price To FCF	5.33
Price To sales	0.46
EV / EBITDA	9.25

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Do Its Financials Have Any Role To Play In Driving Spire Healthcare Group plc's (LON:SPI) Stock Up Recently?

Sep -25

Source:

Spire Healthcare Group First Half 2025 Earnings: EPS Misses Expectations

Aug -02

Source:

Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares

Jun -17

Source:

Stocks to watch this week: Broadcom, Lululemon, British American Tobacco, Dr Martens and Rémy Cointreau

May -30

Source:

UK 'bargain' stocks that have outperformed the market long-term

May -23

Source:

Spire Healthcare Group's (LON:SPI) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar -22

Source:

Earnings Miss: Spire Healthcare Group plc Missed EPS By 37% And Analysts Are Revising Their Forecasts

Mar -09

Source:

Spire Healthcare Group PLC (LSE:SPI) (FY 2024) Earnings Call Highlights: Robust Growth Amidst ...

Mar -07

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (6.86%)

6. Segments

Insured

Expected Growth: 6.5%

Spire Healthcare Group plc's 6.5% growth is driven by increasing demand for private healthcare, an ageing population, and a growing middle class. Additionally, the company's strategic expansion into new markets, investment in digital healthcare, and focus on quality care are contributing to its growth momentum.

Self-pay

Expected Growth: 7.5%

Spire Healthcare Group plc's 7.5% self-pay growth is driven by increasing demand for private healthcare, rising healthcare expenditure, and growing awareness of premium healthcare services. Additionally, the company's strategic partnerships, investments in digital platforms, and expansion of services to cater to the growing demand for elective procedures also contribute to this growth.

National Health Services

Expected Growth: 6.8%

Spire Healthcare Group plc's National Health Services segment growth of 6.8% is driven by increasing demand for private healthcare, NHS outsourcing, and strategic partnerships. Additionally, the company's focus on quality care, investment in digital infrastructure, and expansion of services to meet growing patient needs contribute to its growth momentum.

Other

Expected Growth: 7.2%

Spire Healthcare Group plc's 7.2% growth is driven by increasing demand for private healthcare, expansion of services in existing hospitals, and strategic partnerships with NHS trusts. Additionally, investments in digital transformation and quality improvement initiatives have enhanced patient experience, attracting more patients and driving revenue growth.

7. Detailed Products

Private Hospital Services

Spire Healthcare Group plc provides private hospital services, offering a range of medical and surgical procedures, including orthopaedic, general surgery, and cancer care.

Cancer Care

Spire Healthcare Group plc offers comprehensive cancer care services, including diagnosis, treatment, and support, using advanced technology and treatments.

Orthopaedic Services

Spire Healthcare Group plc provides orthopaedic services, including joint replacements, sports medicine, and spinal care, using advanced surgical techniques.

Diagnostic Services

Spire Healthcare Group plc offers diagnostic services, including imaging, pathology, and physiotherapy, to help diagnose and treat various medical conditions.

Rehabilitation Services

Spire Healthcare Group plc provides rehabilitation services, including physiotherapy, occupational therapy, and speech therapy, to help patients recover from illness or injury.

Wellness and Health Screening

Spire Healthcare Group plc offers wellness and health screening services, including health checks, to help prevent and detect medical conditions.

8. Spire Healthcare Group plc's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Spire Healthcare Group plc is medium due to the presence of alternative healthcare providers and medical tourism.

Bargaining Power Of Customers

The bargaining power of customers for Spire Healthcare Group plc is low due to the lack of negotiating power of individual patients.

Bargaining Power Of Suppliers

The bargaining power of suppliers for Spire Healthcare Group plc is medium due to the presence of multiple suppliers of medical equipment and services.

Threat Of New Entrants

The threat of new entrants for Spire Healthcare Group plc is low due to the high barriers to entry in the healthcare industry.

Intensity Of Rivalry

The intensity of rivalry for Spire Healthcare Group plc is high due to the presence of multiple competitors in the private healthcare industry.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

	Value
Debt Weight	38.53%
Debt Cost	8.77%
Equity Weight	61.47%
Equity Cost	8.77%
WACC	8.77%
Leverage	62.67%

11. Quality Control: Spire Healthcare Group plc passed 3 out of 9 key points

Strong Liquidity

Low Deb

Strong Interest Coverage

Healthy Cash Flow

Operating Efficiency

Strong Return On Equity

Consistent Revenue Growth

Consistent Operating Cash Flow Growth

Margin Improvement

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Terveystalo

A-Score: 6.2/10

Value: 6.8

Growth: 5.4

Quality: 6.1

Yield: 7.5

Momentum: 5.0

Volatility: 6.7

1-Year Total Return ->

Ambea

A-Score: 6.1/10

Value: 6.3

Growth: 7.7

Quality: 4.7

Yield: 3.8

Momentum: 9.0

Volatility: 5.0

1-Year Total Return ->

Attendo

A-Score: 5.5/10

Value: 6.2

Growth: 7.7

Quality: 3.8

Yield: 1.2

Momentum: 9.0

Volatility: 5.0

1-Year Total Return ->

Spire Healthcare

A-Score: 4.4/10

Value: 5.4

Growth: 6.4

Quality: 2.4

Yield: 0.6

Momentum: 6.0

Volatility: 5.3

1-Year Total Return ->

Aevis Victoria

A-Score: 4.4/10

Value: 2.9

Growth: 4.8

Quality: 3.4

Yield: 2.5

Momentum: 5.5

Volatility: 7.0

1-Year Total Return ->

RHOEN-KLINIKUM

A-Score: 4.3/10

Value: 7.9

Growth: 5.6

Quality: 5.2

Yield: 0.6

Momentum: 1.5

Volatility: 5.0

1-Year Total Return ->

Peers Metrics

12.e Scoring ^Insights

12.f DCF ^BETA

Parameters

Short Term Growth

-3.30%

Short term Time

10.0

Long-Term Growth

2.00%

WACC

8.77%

Spire Healthcare Group plc - GB00BNLPYF73

1. Company Snapshot

1.a. Company Description

1.b. Last Insights on SPI

1.c. Company Highlights

Medium Volatility

Average Quality

Stable Momentum

Fairly Valued

Less Volatile

Average Growth

Revenues Miss

Average Yield

Earnings Miss

Cheaper

Lower Quality

Weak Momentum

Earnings Beats

2. Transcript Summary

3. NewsRoom

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (6.86%)

6. Segments

Insured

Expected Growth: 6.5%

Self-pay

Expected Growth: 7.5%

National Health Services

Expected Growth: 6.8%

Other

Expected Growth: 7.2%

7. Detailed Products

Private Hospital Services

Cancer Care

Orthopaedic Services

Diagnostic Services

Rehabilitation Services

Wellness and Health Screening

8. Spire Healthcare Group plc's Porter Forces

Forces Ranking

Threat Of Substitutes

Bargaining Power Of Customers

Bargaining Power Of Suppliers

Threat Of New Entrants

Intensity Of Rivalry

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

11. Quality Control: Spire Healthcare Group plc passed 3 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

1.76$

Current Price

1.76$

Potential

-0.00%

Expected Cash-Flows

12.e Scoring ^Insights

12.f DCF ^BETA